Key facts
- Lazurite’s last known valuation is $167.0M (Jan 2025).
- It has raised $30.9M across 1 recorded rounds; the latest was Seed Round ($1.7M) in Dec 2024.
- Notable investors include MedTech Innovator, University Hospitals Ventures, AUA Capital Management, AngelMD, Moontide Capital — 6 tracked in total.
- Lazurite has filed 1 Form D with the SEC, most recently Jan 2025 ($1.7M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Lazurite
Funding rounds
1 roundsAbout Lazurite
Developer of light and camera technologies designed to build safer surgical devices. The company specializes in transformative surgical wireless platforms, laser-based lighting, and other advanced technologies in a modular wireless surgical camera system for minimally invasive surgery, enabling the medical community and surgeons with alternatives to cumbersome wires and outdated technology by making surgery safer and more efficient.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2015
- Employees
- 31
- Website
- lazurite.co/
- Ownership
- Privately Held (backing)
Lazurite doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lazurite shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lazurite in its N-PORT filings yet. We sweep new filings monthly.